Bouffard DY - Search Results

1

Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.

Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G. Gourdeau H, et al. Among authors: bouffard dy. Cancer Chemother Pharmacol. 2002 Dec;50(6):490-6. doi: 10.1007/s00280-002-0530-7. Epub 2002 Oct 16. Cancer Chemother Pharmacol. 2002. PMID: 12451476

2

BCH-1868 [(-)-2-R-dihydroxyphosphinoyl-5-(S)-(guanin-9'-yl-methyl) tetrahydrofuran]: a cyclic nucleoside phosphonate with antitumor activity.

Leblond L, Attardo G, Hamelin B, Bouffard DY, Nguyen-Ba N, Gourdeau H. Leblond L, et al. Among authors: bouffard dy. Mol Cancer Ther. 2002 Jul;1(9):737-46. Mol Cancer Ther. 2002. PMID: 12479370

3

Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.

Bouffard DY, Jolivet J, Leblond L, Hamelin B, Ouellet F, Barbeau S, Richard A, Gourdeau H. Bouffard DY, et al. Cancer Chemother Pharmacol. 2003 Dec;52(6):497-506. doi: 10.1007/s00280-003-0699-4. Epub 2003 Sep 3. Cancer Chemother Pharmacol. 2003. PMID: 12955470

4

Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.

Damaraju VL, Bouffard DY, Wong CK, Clarke ML, Mackey JR, Leblond L, Cass CE, Grey M, Gourdeau H. Damaraju VL, et al. Among authors: bouffard dy. BMC Cancer. 2007 Jul 3;7:121. doi: 10.1186/1471-2407-7-121. BMC Cancer. 2007. PMID: 17608948 Free PMC article.

5

Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity.

Kasibhatla S, Gourdeau H, Meerovitch K, Drewe J, Reddy S, Qiu L, Zhang H, Bergeron F, Bouffard D, Yang Q, Herich J, Lamothe S, Cai SX, Tseng B. Kasibhatla S, et al. Mol Cancer Ther. 2004 Nov;3(11):1365-74. Mol Cancer Ther. 2004. PMID: 15542775

6

Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.

Kemnitzer W, Drewe J, Jiang S, Zhang H, Wang Y, Zhao J, Jia S, Herich J, Labreque D, Storer R, Meerovitch K, Bouffard D, Rej R, Denis R, Blais C, Lamothe S, Attardo G, Gourdeau H, Tseng B, Kasibhatla S, Cai SX. Kemnitzer W, et al. J Med Chem. 2004 Dec 2;47(25):6299-310. doi: 10.1021/jm049640t. J Med Chem. 2004. PMID: 15566300

7

Oligonucleotides as modulators of cancer gene expression.

Curcio LD, Bouffard DY, Scanlon KJ. Curcio LD, et al. Among authors: bouffard dy. Pharmacol Ther. 1997;74(3):317-32. doi: 10.1016/s0163-7258(97)00005-3. Pharmacol Ther. 1997. PMID: 9352587 Review.

8

Anti-oncogene ribozymes for cancer gene therapy.

Irie A, Kijima H, Ohkawa T, Bouffard DY, Suzuki T, Curcio LD, Holm PS, Sassani A, Scanlon KJ. Irie A, et al. Among authors: bouffard dy. Adv Pharmacol. 1997;40:207-57. doi: 10.1016/s1054-3589(08)60141-6. Adv Pharmacol. 1997. PMID: 9217927 Review. No abstract available.

9

Oligonucleotide modulation of multidrug resistance.

Bouffard DY, Ohkawa T, Kijima H, Irie A, Suzuki T, Curcio LD, Holm PS, Sassani A, Scanlon KJ. Bouffard DY, et al. Eur J Cancer. 1996 Jun;32A(6):1010-8. doi: 10.1016/0959-8049(96)00065-2. Eur J Cancer. 1996. PMID: 8763342 Review. No abstract available.

10

Ribozyme-mediated cancer gene therapy.

Irie A, Bouffard DY, Scanlon KJ. Irie A, et al. Among authors: bouffard dy. Int J Urol. 1997 Jul;4(4):329-37. doi: 10.1111/j.1442-2042.1997.tb00203.x. Int J Urol. 1997. PMID: 9256319 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page